Molecular Cancer Therapeutics

Edit Your Profile

Molecular Cancer Therapeutics Journal

publication venue for

The Existence of MTH1-independent 8-oxodGTPase Activity in Cancer Cells as a Compensatory Mechanism against On-target Effects of MTH1 Inhibitors. 19:432-446. 2020
Mechanisms Behind Resistance to P13K Inhibitor Treatment Induced by the PIM Kinase. 17:2710-2721. 2018
Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells. 16:2387-2398. 2017
A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer. 16:625-636. 2017
Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-κB activity via direct interaction with p50. 8:1613-1624. 2009
Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line. 8:1197-1206. 2009
Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells. 7:3298-3305. 2008
Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. 6:957-966. 2007
Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. 6:154-162. 2007
Multiple comparisons model-based clustering and ternary pattern tree numerical display of gene response to treatment: Procedure and application to the preclinical evaluation of chemopreventive agents. 1:1283-1292. 2002
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer 2021
EGFRvIII expression is associated with shorter progression-free and overall survival in glioblastoma patients treated with standard-of-care temozolomide and radiation: A report from the RTOG-0525 trial. 2013
Abstract A99: Phase I trial of veliparib or mitomycin C + veliparib in pts with Fanconi anemia pathway (FA) repair defects. 2011

International Standard Serial Number (ISSN)

1535-7163

Electronic International Standard Serial Number (EISSN)

1538-8514